Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer.

MLA

Sotiropoulos, George P., et al. “Chemerin as a Biomarker at the Intersection of Inflammation, Chemotaxis, Coagulation, Fibrinolysis and Metabolism in Resectable Non-Small Cell Lung Cancer.” Lung Cancer (01695002), vol. 125, Nov. 2018, pp. 291–99. EBSCOhost, https://doi.org/10.1016/j.lungcan.2018.10.010.

APA

Sotiropoulos, G. P., Dalamaga, M., Antonakos, G., Marinou, I., Vogiatzakis, E., Kotopouli, M., Karampela, I., Christodoulatos, G. S., Lekka, A., & Papavassiliou, A. G. (2018). Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer. Lung Cancer (01695002), 125, 291–299. https://doi.org/10.1016/j.lungcan.2018.10.010

Chicago

Sotiropoulos, George P., Maria Dalamaga, Georgios Antonakos, Ioanna Marinou, Evaggelos Vogiatzakis, Marianna Kotopouli, Irene Karampela, Gerasimos Socrates Christodoulatos, Antigoni Lekka, and Athanasios G. Papavassiliou. 2018. “Chemerin as a Biomarker at the Intersection of Inflammation, Chemotaxis, Coagulation, Fibrinolysis and Metabolism in Resectable Non-Small Cell Lung Cancer.” Lung Cancer (01695002) 125 (November): 291–99. doi:10.1016/j.lungcan.2018.10.010.